Click Here to return To Results

 

Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis Arch Neurol 65:1044-1051, Krishnan,C.,et al., 2008 See this aricle in Pubmed Article Abstract Treatment with HiCy was safe and well tolerated in our patients with MS. Patients experienced a pronounced reduction n disease activity and disability after HiCy treatment. This immunoablative regimen of cyclophosphamide for patients with aggressive MS is worthy of further study and may be an alternative to bone marrow transplantation.

Related Tags

(click to filter results - removes previous filter) cyclophosphamide disability,neurological efficacy immunosuppressive agents MRI,contrast enhanced multiple sclerosis multiple sclerosis,acute multiple sclerosis,aggressive multiple sclerosis,disability status scale multiple sclerosis,relapsing multiple sclerosis,treatment of safety treatment of neurologic disorder

Click Here to return To Results